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Background Data on the relation of infarct size and microvascular obstruction (MO) assessed with magnetic resonance imaging (MRI) as 
predictors for adverse clinical outcome after ST-elevation myocardial infarction (STEMI) are not consistent. In addition, the ratio of MO and infarct 
size might be an even stronger predictor for outcome after STEMI which has not been investigated, yet.
Methods STEMI patients reperfused by primary angioplasty (n=423) within 12 hours after symptom onset underwent MRI at a median of 3 days 
after the index event (IQR 2-4). MO and infarct size were measured 15 minutes after gadolinium injection with late enhancement sequences and 
were analyzed quantitatively (as percentage of the left ventricular mass [%LV]). Clinical follow-up was conducted after 19 months (IQR 10-27). The 
primary endpoint was defined as composite of death, non-fatal myocardial reinfarction and congestive heart failure.
Results The extent of MO was moderately correlated with infarct size (r=0.21, p<0.001), as patients with MO displayed a significantly greater 
infarct expansion compared to patients without MO (22.4 [13.4;31.7] vs. 6.1 [1.8;14.5] %LV, p<0.001). In comparison to MO and infarct size, the 
ratio of MO and infarct size was the strongest predictor for MACE in univariable analysis (hazard ratio [HR] 1.83, 95%CI 1.34-2.50, p<0.001). In a 
first multivariable analysis including infarct size, ejection fraction and end-systolic volume and end-diastolic volume, MO was the only parameter 
independently associated with MACE (HR 1.03, 95%CI 1.01-1.04, p=0.001). In a second multivariable analysis including the ratio of MO and infarct 
size on top of MO, infarct size, ejection fraction and end-systolic volume, and end-diastolic volume, the ratio of MO and infarct size was (HR of 2.05; 
95%CI 1.01-4.14, p=0.04) identified as the strongest independent predictor for MACE.
Conclusion  Although in contrast to infarct size, MO is associated with adverse clinical outcome after STEMI even after adjustment for other MRI 
parameters, the ratio of MO and infarct size is a more powerful predictor for long-term outcome after STEMI adding incremental prognostic value 
above the separate analysis of these parameters.
